NBVM GP, LLC

Track

Insider profile

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 35% 8.2% 15.1%
Success rate 54% 68% 82%
Transactions
9 67% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
NBVM GP, LLC's trades of Lyra Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-06-02 2023-05-31
B Purchase
62,529 -41.7%
484.18
US$240,823 		62,529 -41.7% 484.18 US$240,823
2023-06-02 2023-05-31
B Purchase
80,492 +40.6%
358.34
US$2,138,138 		80,492 +40.6% 358.34 US$2,138,138
2023-06-02 2023-05-31
B Purchase
90,716 -12.8%
112.55
US$4,373,166 		90,716 -12.8% 112.55 US$4,373,166
2022-04-14 2022-04-12
B Purchase
765,010 +138.3%
4.22
US$3,228,342 		765,010 +138.3% 4.22 US$3,228,342
2022-04-14 2022-04-12
B Purchase
527,806 +138.3%
4.22
US$2,227,341 		527,806 +138.3% 4.22 US$2,227,341
2022-04-14 2022-04-12
B Purchase
1,076,851 +138.3%
4.22
US$4,544,311 		1,076,851 +138.3% 4.22 US$4,544,311
2020-05-06 2020-05-05
B Purchase
75,000 +15.7%
16.00
US$1,200,000 		75,000 +15.7% 16.00 US$1,200,000
2020-05-06 2020-05-05
B Purchase
57,561 +17.8%
16.00
US$920,976 		57,561 +17.8% 16.00 US$920,976
2020-05-06 2020-05-05
B Purchase
117,439 +17.8%
16.00
US$1,879,024 		117,439 +17.8% 16.00 US$1,879,024
2020-05-06 2020-05-05
S Sale
7,255 -1.5%
16.00
US$116,080 		7,255 -1.5% 16.00 US$116,080
2020-05-06 2020-05-05
S Sale
5,568 -1.7%
16.00
US$89,088 		5,568 -1.7% 16.00 US$89,088
2020-05-06 2020-05-05
S Sale
11,360 -1.7%
16.00
US$181,760 		11,360 -1.7% 16.00 US$181,760